Skype
Telecommunications application software
Skype is a telecommunications application that provides videotelephony, voice calls, and instant messaging services. It was first released in August 2003 and was created by a team of developers from Estonia. Skype allows users to communicate over the Internet by voice using a microphone, by video using a webcam, and by instant messaging. Skype also provides services such as file transfer, debit-based calls to landline and mobile telephones, and other features.
History
Skype was founded in 2003 by Niklas Zennström and Janus Friis. The software was developed by Estonians Ahti Heinla, Priit Kasesalu, and Jaan Tallinn. In 2005, Skype was acquired by eBay for $2.6 billion. In 2011, Microsoft acquired Skype for $8.5 billion, integrating it into their suite of products and services.
Features
Skype offers a variety of features, including:
- Videotelephony: Users can make video calls to other Skype users.
- Voice over IP: Users can make voice calls to other Skype users.
- Instant messaging: Users can send text messages to other Skype users.
- File transfer: Users can send files to other Skype users.
- Screen sharing: Users can share their screens with other Skype users.
- Skype-to-phone calls: Users can call landline and mobile phones using Skype credit.
Platforms
Skype is available on multiple platforms, including:
Usage
Skype is widely used for both personal and business communication. It is popular for keeping in touch with family and friends, as well as for conducting business meetings and interviews. Skype for Business, a version of Skype designed for enterprise use, integrates with Microsoft Office and provides additional features for business users.
See also
Related pages
- Videotelephony
- Voice over IP
- Instant messaging
- Microsoft
- Microsoft Teams
- Zoom Video Communications
- Google Meet
- FaceTime
Microsoft | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD